The Stellant D CT Injection System is a full-featured, dual syringe injection system that reportedly enables clinicians to perform the most critical CT contrast exams, including cardiac CT and Coronary CTA, with advances like DualFlow simultaneous saline and contrast delivery, P3T Cardiac personalized patient protocol, XDS Extravasation Detector and the Medrad Informatics System to integrate injection data with the patient image set.
For more information: www.medrad.com
Oct. 27, 2026 – Bracco has announced plans to invest $230 million to establish its first U.S. manufacturing facility for ...
October 28, 2026 
Aug. 11, 2026 — Bracco Imaging recently announced that VueJect, its dedicated ultrasound contrast delivery system ...
August 12, 2026 
June 15, 2026 – Bayer has announced that the U.S. Food and Drug Administration (FDA) approved Ambelvist (gadoquatrane) ...
June 16, 2026 
May 18, 2026 — ACIST Medical Systems, a Bracco company, has received U.S. Food and Drug Administration (FDA) clearance ...
May 18, 2026 
March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...
March 04, 2026 